Literature DB >> 8895478

Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas.

N M Probst-Hensch1, R W Haile, D S Li, G T Sakamoto, A D Louie, B K Lin, H D Frankl, E R Lee, H J Lin.   

Abstract

Smoking and a high intake of red meat are risk factors for colorectal tumors. These effects could be due to aromatic amine carcinogens. Individual susceptibility to aromatic amines has been related to acetylation phenotype, which plays a role in the bioactivation of arylamines. Polymorphisms in both N-acetyltransferase genes, NAT1 and NAT2, have been associated with an increased risk of colorectal tumors. We studied the NAT1*10 fast acetylator allele (1088 T-->A mutation) and distal adenomas in a sigmoidoscopy-based case-control study (441 cases, 484 controls). We found neither an increased adenoma prevalence in subjects homozygous or heterozygous for the NAT1*10 fast acetylator allele (odds ratio 1.04; 95% confidence interval 0.79-1.36), nor a gene-gene interaction between NA1 and NAT2 (P(interaction) = 0.59). Further NAT1 alleles must be considered for more conclusive results regarding the relevance of NAT1 activity to colorectal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8895478     DOI: 10.1093/carcin/17.10.2125

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

1.  N-Acetyltransferase polymorphism and human cancer risk.

Authors:  X Yang; T Takeshita; K Morimoto
Journal:  Environ Health Prev Med       Date:  2000-01       Impact factor: 3.674

2.  Expression of arylamine N-acetyltransferase in human intestine.

Authors:  D Hickman; J Pope; S D Patil; G Fakis; V Smelt; L A Stanley; M Payton; J D Unadkat; E Sim
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

3.  N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia.

Authors:  Azza M Kamel; Gamal T A Ebid; Heba S Moussa
Journal:  Tumour Biol       Date:  2015-03-25

4.  NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis.

Authors:  Kunyi Zhang; Lijuan Gao; Yuqi Wu; Jianyi Chen; Chengguang Lin; Shaohua Liang; Jianxin Su; Jinming Ye; Xuyu He
Journal:  Int J Clin Exp Med       Date:  2015-06-15

5.  Meat intake, heterocyclic amine exposure, and metabolizing enzyme polymorphisms in relation to colorectal polyp risk.

Authors:  Aesun Shin; Martha J Shrubsole; Jeffrey M Rice; Qiuyin Cai; Mark A Doll; Jirong Long; Walter E Smalley; Yu Shyr; Rashmi Sinha; Reid M Ness; David W Hein; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-02       Impact factor: 4.254

6.  N-acetyltransferase polymorphism and risk of colorectal adenoma and cancer: a pooled analysis of variations from 59 studies.

Authors:  Jinxin Liu; Dapeng Ding; Xiaoxue Wang; Yizhi Chen; Rong Li; Ying Zhang; Rongcheng Luo
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

Review 7.  Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer.

Authors:  A Hirvonen
Journal:  Environ Health Perspect       Date:  1999-02       Impact factor: 9.031

8.  Association of NAT2 polymorphisms with risk of colorectal adenomas: Evidence from 3,197 cases and 4,681 controls.

Authors:  Wenlei Zhuo; Liang Zhang; Zhiqun Qiu; Lei Cai; Bo Zhu; Zhengtang Chen
Journal:  Exp Ther Med       Date:  2012-09-04       Impact factor: 2.447

9.  N-Acetyltransferase 1 (NAT1) Genotype: A Risk Factor for Urinary Bladder Cancer in a Lebanese Population.

Authors:  Ibrahim A Yassine; Loulou Kobeissi; Michel E Jabbour; Hassan R Dhaini
Journal:  J Oncol       Date:  2012-08-22       Impact factor: 4.375

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.